| dc.contributor.author | Korfi, K | en_US |
| dc.contributor.author | Ali, S | en_US |
| dc.contributor.author | Heward, JA | en_US |
| dc.contributor.author | Fitzgibbon, J | en_US |
| dc.date.accessioned | 2017-01-31T14:29:19Z | |
| dc.date.available | 2017-01-10 | en_US |
| dc.date.issued | 2017 | en_US |
| dc.date.submitted | 2017-01-30T10:45:04.206Z | |
| dc.identifier.issn | 1559-2294 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/19089 | |
| dc.description.sponsorship | K Korfi, S Ali, J Heward and J Fitzgibbon are supported by Cancer Research UK Programme Grant
[C15966/A15968] and Bloodwise Programme Grant [15002]. S Ali is also a recipient of Cancer
Research UK Clinical Careers Committee research bursary [C56515/A21397]. | en_US |
| dc.format.extent | 370 - 377 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | EPIGENETICS | en_US |
| dc.rights | This is an Accepted Manuscript of an article published by Taylor & Francis Group in Epigenetics on 20 Jan 2017, available online: http://www.tandfonline.com/10.1080/15592294.2017.1282587 | |
| dc.subject | Epigenetic mutations | en_US |
| dc.subject | epigenetic therapies | en_US |
| dc.subject | EZH2 inhibitors | en_US |
| dc.subject | follicular lymphoma | en_US |
| dc.subject | HDAC inhibitors | en_US |
| dc.title | Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations | en_US |
| dc.type | Article | |
| dc.identifier.doi | 10.1080/15592294.2017.1282587 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000402101900006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 5 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 12 | en_US |
